Clinical Trials Revolutionize Patient’s Liver Disease
After diagnosis with liver disease, patient Rosa Tellez-Moore opts to participate in clinical trials, which change the trajectory of her treatment.
After diagnosis with liver disease, patient Rosa Tellez-Moore opts to participate in clinical trials, which change the trajectory of her treatment.
In a new study, researchers from UC San Diego designed experiments to show how disordered energy can limit the energy transfer pathway of polaritons, and further demonstrated a strategy to overcome this limitation.
Researchers have developed a novel method to stimulate and mature human brain organoids using graphene, a one-atom-thick sheet of carbon.
The California Institute for Regenerative Medicine (CIRM) Scholars program seeks to develop skilled leaders in the field of regenerative medicine who create safe, cutting-edge stem cell treatments for diseases without cure like cancer, diabetes, heart disease and HIV.
Undergraduates from around the country recently gathered at the UC San Diego Qualcomm Institute to present the outcomes of their nanotechnology summer research projects.
University of California San Diego recently welcomed the U.S. Food and Drug Administration (FDA) Commissioner Martin Makary, M.D., M.P.H., to its Moores Cancer Center for a pivotal industry town hall.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.